Alteration of macrophage differentiation into accessory and effector cells from exposure to dimethylnitrosamine (DMN) in vivo

Michael J. Myers, Jeffrey K. Pullen, Lawrence B Schook

Research output: Contribution to journalArticle

Abstract

DMN exposure modulates cellular immunity through alterations in the maturation and hematopoieses of macrophages. DMN-exposed bone marrow stem cells gave rise to increased colony-forming unit-macrophage (CFU-M) colonies while the resulting colonies produced fewer cells/colony. Bone marrow-derived macrophages phenotypically had decreased cells expressing Ia antigens or cells in the S-phase following DMN treatment. Concanavalin A-elicited peritoneal exudate cells from DMN-treated animals demonstrated an increase in the percentage of macrophages and in the number of immature, bi-nucleated cells obtained as well as a concomitant increase in the percentage of Ia antigen-expressing cells. Concanavalin A-elicited peritoneal exudate cells from DMN-exposed animals also had an increased secreted interleukin-1 activity following lipopolysaccharide stimulation without any alteration in the expression of membrane-bound interleukin-1. Thioglycolate-elicited peritoneal exudate cells from DMN-exposed animals demonstrated no changes in cellularity and only showed increases in the percentage of bi-nucleated cells. There were no alterations in the capacity of T cells obtained from DMN-treated animals to respond to either soluble (keyhole limpet hemocyanin) or allo-antigens; nor were there alterations in the capacity of these T cells to either produce or respond to interleukin-2. These findings suggest that the observed DMN-induced modulation(s) in cell-mediated immunity results from changes in macrophage hematopoieses due to alterations in: (1) the production of regulatory factors controlling their production and/or differentiation or (2) their ability to respond to these factors.

Original languageEnglish (US)
Pages (from-to)105-115
Number of pages11
JournalImmunopharmacology
Volume12
Issue number2
DOIs
StatePublished - Jan 1 1986
Externally publishedYes

Fingerprint

Dimethylnitrosamine
Macrophages
Exudates and Transudates
Histocompatibility Antigens Class II
Concanavalin A
Interleukin-1
Cellular Immunity
Stem Cells
Thioglycolates
T-Lymphocytes
S Phase
Bone Marrow Cells
Interleukin-2
Lipopolysaccharides
Antigens
Membranes

Keywords

  • Bone marrow-derived macrophage
  • Dimethylnitrosamine
  • Macrophage heterogeneity

ASJC Scopus subject areas

  • Pharmacology

Cite this

Alteration of macrophage differentiation into accessory and effector cells from exposure to dimethylnitrosamine (DMN) in vivo. / Myers, Michael J.; Pullen, Jeffrey K.; Schook, Lawrence B.

In: Immunopharmacology, Vol. 12, No. 2, 01.01.1986, p. 105-115.

Research output: Contribution to journalArticle

@article{eb08925f7d454a8487a28095f6d17820,
title = "Alteration of macrophage differentiation into accessory and effector cells from exposure to dimethylnitrosamine (DMN) in vivo",
abstract = "DMN exposure modulates cellular immunity through alterations in the maturation and hematopoieses of macrophages. DMN-exposed bone marrow stem cells gave rise to increased colony-forming unit-macrophage (CFU-M) colonies while the resulting colonies produced fewer cells/colony. Bone marrow-derived macrophages phenotypically had decreased cells expressing Ia antigens or cells in the S-phase following DMN treatment. Concanavalin A-elicited peritoneal exudate cells from DMN-treated animals demonstrated an increase in the percentage of macrophages and in the number of immature, bi-nucleated cells obtained as well as a concomitant increase in the percentage of Ia antigen-expressing cells. Concanavalin A-elicited peritoneal exudate cells from DMN-exposed animals also had an increased secreted interleukin-1 activity following lipopolysaccharide stimulation without any alteration in the expression of membrane-bound interleukin-1. Thioglycolate-elicited peritoneal exudate cells from DMN-exposed animals demonstrated no changes in cellularity and only showed increases in the percentage of bi-nucleated cells. There were no alterations in the capacity of T cells obtained from DMN-treated animals to respond to either soluble (keyhole limpet hemocyanin) or allo-antigens; nor were there alterations in the capacity of these T cells to either produce or respond to interleukin-2. These findings suggest that the observed DMN-induced modulation(s) in cell-mediated immunity results from changes in macrophage hematopoieses due to alterations in: (1) the production of regulatory factors controlling their production and/or differentiation or (2) their ability to respond to these factors.",
keywords = "Bone marrow-derived macrophage, Dimethylnitrosamine, Macrophage heterogeneity",
author = "Myers, {Michael J.} and Pullen, {Jeffrey K.} and Schook, {Lawrence B}",
year = "1986",
month = "1",
day = "1",
doi = "10.1016/0162-3109(86)90036-6",
language = "English (US)",
volume = "12",
pages = "105--115",
journal = "Immunopharmacology",
issn = "0162-3109",
publisher = "Elsevier BV",
number = "2",

}

TY - JOUR

T1 - Alteration of macrophage differentiation into accessory and effector cells from exposure to dimethylnitrosamine (DMN) in vivo

AU - Myers, Michael J.

AU - Pullen, Jeffrey K.

AU - Schook, Lawrence B

PY - 1986/1/1

Y1 - 1986/1/1

N2 - DMN exposure modulates cellular immunity through alterations in the maturation and hematopoieses of macrophages. DMN-exposed bone marrow stem cells gave rise to increased colony-forming unit-macrophage (CFU-M) colonies while the resulting colonies produced fewer cells/colony. Bone marrow-derived macrophages phenotypically had decreased cells expressing Ia antigens or cells in the S-phase following DMN treatment. Concanavalin A-elicited peritoneal exudate cells from DMN-treated animals demonstrated an increase in the percentage of macrophages and in the number of immature, bi-nucleated cells obtained as well as a concomitant increase in the percentage of Ia antigen-expressing cells. Concanavalin A-elicited peritoneal exudate cells from DMN-exposed animals also had an increased secreted interleukin-1 activity following lipopolysaccharide stimulation without any alteration in the expression of membrane-bound interleukin-1. Thioglycolate-elicited peritoneal exudate cells from DMN-exposed animals demonstrated no changes in cellularity and only showed increases in the percentage of bi-nucleated cells. There were no alterations in the capacity of T cells obtained from DMN-treated animals to respond to either soluble (keyhole limpet hemocyanin) or allo-antigens; nor were there alterations in the capacity of these T cells to either produce or respond to interleukin-2. These findings suggest that the observed DMN-induced modulation(s) in cell-mediated immunity results from changes in macrophage hematopoieses due to alterations in: (1) the production of regulatory factors controlling their production and/or differentiation or (2) their ability to respond to these factors.

AB - DMN exposure modulates cellular immunity through alterations in the maturation and hematopoieses of macrophages. DMN-exposed bone marrow stem cells gave rise to increased colony-forming unit-macrophage (CFU-M) colonies while the resulting colonies produced fewer cells/colony. Bone marrow-derived macrophages phenotypically had decreased cells expressing Ia antigens or cells in the S-phase following DMN treatment. Concanavalin A-elicited peritoneal exudate cells from DMN-treated animals demonstrated an increase in the percentage of macrophages and in the number of immature, bi-nucleated cells obtained as well as a concomitant increase in the percentage of Ia antigen-expressing cells. Concanavalin A-elicited peritoneal exudate cells from DMN-exposed animals also had an increased secreted interleukin-1 activity following lipopolysaccharide stimulation without any alteration in the expression of membrane-bound interleukin-1. Thioglycolate-elicited peritoneal exudate cells from DMN-exposed animals demonstrated no changes in cellularity and only showed increases in the percentage of bi-nucleated cells. There were no alterations in the capacity of T cells obtained from DMN-treated animals to respond to either soluble (keyhole limpet hemocyanin) or allo-antigens; nor were there alterations in the capacity of these T cells to either produce or respond to interleukin-2. These findings suggest that the observed DMN-induced modulation(s) in cell-mediated immunity results from changes in macrophage hematopoieses due to alterations in: (1) the production of regulatory factors controlling their production and/or differentiation or (2) their ability to respond to these factors.

KW - Bone marrow-derived macrophage

KW - Dimethylnitrosamine

KW - Macrophage heterogeneity

UR - http://www.scopus.com/inward/record.url?scp=0022442733&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022442733&partnerID=8YFLogxK

U2 - 10.1016/0162-3109(86)90036-6

DO - 10.1016/0162-3109(86)90036-6

M3 - Article

VL - 12

SP - 105

EP - 115

JO - Immunopharmacology

JF - Immunopharmacology

SN - 0162-3109

IS - 2

ER -